The share price of NZX-listed cancer diagnostic company Pacific Edge has spiked to 18 cents in trading today, from 10c at the start of the week as investors have seemingly got excited at a small sign of good news on the US test front.
The company’s not commenting on the share price move, which
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
